{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:17:44Z","timestamp":1788895064753,"version":"build-2803163510"},"reference-count":55,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Transcription factor Forkhead box P1 (FOXP1) belongs to the same protein family as the FOXOs that are well-known regulators of murine hematopoietic stem progenitor cell (HSPC) maintenance via dampening oxidative stress. FOXP1 and FOXOs can play opposite, or similar, roles depending on cell context; they can crossregulate each other\u2019s expression. In a previous study, we have shown that FOXP1 contributes to healthy human HSPC and acute myeloid leukemia (AML) cell growth. Here, we investigated the role of FOXP1 in HSPCs and AML cell oxidative stress defense in a human context. FOXP1 expression level was associated with an inferior survival outcome in patients with cytogenetically normal AML. FOXP1 knockdown enhanced superoxide anion levels of human-committed CD34+CD38+ cells but not stem cell\u2013enriched CD34+CD38\u2212 HSPCs or AML cells in\u00a0vitro. FOXP1 knockdown triggered enhanced NRF2 activity and increased cell oxidative stress. FOXP1 had no impact on FOXO1\/3\/4 expression in these cells; genetic and pharmacological inhibition of FOXOs did not change superoxide anion levels of human HSPCs or AML cells. Moreover, FOXP1 antioxidant activity was independent of changes in expression of superoxide dismutase 1 and 2 or catalase. Instead, FOXP1 upregulated expression of the stress sensor SIRT1 by stabilizing SIRT1 protein. FOXP1 loss sensitized AML cells to chemotherapy. Together, this study identified FOXP1 as a new safeguard against myeloid progenitor oxidative stress, which works independently of FOXOs but through SIRT1 and contributes to AML chemoresistance. It proposes FOXP1 expression\/activity as a promising target to overcome drug resistance of AML HSPCs.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022008585","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T19:14:27Z","timestamp":1679080467000},"page":"3265-3275","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":24,"title":["FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cells"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6775-4542","authenticated-orcid":false,"given":"Francoise","family":"Levavasseur","sequence":"first","affiliation":[{"name":"1Institut Cochin, INSERM U1016, CNRS UMR8104, Universit\u00e9 de Paris, Paris, France"},{"name":"2OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Oussous","sequence":"additional","affiliation":[{"name":"1Institut Cochin, INSERM U1016, CNRS UMR8104, Universit\u00e9 de Paris, Paris, France"},{"name":"2OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8271-3428","authenticated-orcid":false,"given":"Tuerdi","family":"Zubaidan","sequence":"additional","affiliation":[{"name":"1Institut Cochin, INSERM U1016, CNRS UMR8104, Universit\u00e9 de Paris, Paris, France"},{"name":"2OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Kosmider","sequence":"additional","affiliation":[{"name":"1Institut Cochin, INSERM U1016, CNRS UMR8104, Universit\u00e9 de Paris, Paris, France"},{"name":"2OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France"},{"name":"3Assistance Publique-H\u00f4pitaux de Paris, Centre-Universit\u00e9 de Paris, Service d'H\u00e9matologie clinique, H\u00f4pital Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Pendino","sequence":"additional","affiliation":[{"name":"1Institut Cochin, INSERM U1016, CNRS UMR8104, Universit\u00e9 de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8910-0945","authenticated-orcid":false,"given":"David","family":"Rombaut","sequence":"additional","affiliation":[{"name":"1Institut Cochin, INSERM U1016, CNRS UMR8104, Universit\u00e9 de Paris, Paris, France"},{"name":"2OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Bouscary","sequence":"additional","affiliation":[{"name":"1Institut Cochin, INSERM U1016, CNRS UMR8104, Universit\u00e9 de Paris, Paris, France"},{"name":"2OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France"},{"name":"3Assistance Publique-H\u00f4pitaux de Paris, Centre-Universit\u00e9 de Paris, Service d'H\u00e9matologie clinique, H\u00f4pital Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Fontenay","sequence":"additional","affiliation":[{"name":"1Institut Cochin, INSERM U1016, CNRS UMR8104, Universit\u00e9 de Paris, Paris, France"},{"name":"2OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France"},{"name":"3Assistance Publique-H\u00f4pitaux de Paris, Centre-Universit\u00e9 de Paris, Service d'H\u00e9matologie clinique, H\u00f4pital Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4643-6857","authenticated-orcid":false,"given":"Evelyne","family":"Lauret","sequence":"additional","affiliation":[{"name":"1Institut Cochin, INSERM U1016, CNRS UMR8104, Universit\u00e9 de Paris, Paris, France"},{"name":"2OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9286-1021","authenticated-orcid":false,"given":"Isabelle","family":"Dusanter-Fourt","sequence":"additional","affiliation":[{"name":"1Institut Cochin, INSERM U1016, CNRS UMR8104, Universit\u00e9 de Paris, Paris, France"},{"name":"2OPALE Carnot Institute, The Organization for Partnerships in Leukemia, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"issue":"2","key":"2023071017373770400_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cell.2007.01.003","article-title":"FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress","volume":"128","author":"Tothova","year":"2007","journal-title":"Cell"},{"issue":"4","key":"2023071017373770400_bib2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm1388","article-title":"Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells","volume":"12","author":"Ito","year":"2006","journal-title":"Nat Med"},{"issue":"1","key":"2023071017373770400_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.celrep.2019.03.009","article-title":"The hematopoietic oxidase NOX2 regulates self-renewal of leukemic stem cells","volume":"27","author":"Adane","year":"2019","journal-title":"Cell Rep"},{"issue":"7","key":"2023071017373770400_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"2023071017373770400_bib5","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3324\/haematol.2011.054734","article-title":"Recent advances in acute myeloid leukemia stem cell biology","volume":"97","author":"Horton","year":"2012","journal-title":"Haematologica"},{"issue":"7","key":"2023071017373770400_bib6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov"},{"issue":"20","key":"2023071017373770400_bib7","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1158\/0008-5472.CAN-19-0515","article-title":"Targeting myeloperoxidase disrupts mitochondrial redox balance and overcomes cytarabine resistance in human acute myeloid leukemia","volume":"79","author":"Hosseini","year":"2019","journal-title":"Cancer Res"},{"key":"2023071017373770400_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.redox.2015.06.019","article-title":"Redox regulation of FoxO transcription factors","volume":"6","author":"Klotz","year":"2015","journal-title":"Redox Biol"},{"issue":"2","key":"2023071017373770400_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.stem.2007.07.017","article-title":"FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system","volume":"1","author":"Tothova","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"5666","key":"2023071017373770400_bib10","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.1094637","article-title":"Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase","volume":"303","author":"Brunet","year":"2004","journal-title":"Science"},{"issue":"10","key":"2023071017373770400_bib11","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2016-11-750976","article-title":"A\u00a0FOXO1-induced oncogenic network defines the AML1-ETO preleukemic program","volume":"130","author":"Lin","year":"2017","journal-title":"Blood"},{"issue":"5","key":"2023071017373770400_bib12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cell.2011.07.032","article-title":"AKT\/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias","volume":"146","author":"Sykes","year":"2011","journal-title":"Cell"},{"issue":"7","key":"2023071017373770400_bib13","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1517\/14728222.11.7.955","article-title":"FOXP1: a potential therapeutic target in cancer","volume":"11","author":"Koon","year":"2007","journal-title":"Expert Opin Ther Targets"},{"issue":"11","key":"2023071017373770400_bib14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrc2223","article-title":"The emerging roles of forkhead box (Fox) proteins in cancer","volume":"7","author":"Myatt","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2023071017373770400_bib15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ni.2034","article-title":"Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells","volume":"12","author":"Feng","year":"2011","journal-title":"Nat Immunol"},{"issue":"9","key":"2023071017373770400_bib16","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/cdd.2013.81","article-title":"FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis","volume":"20","author":"van Boxtel","year":"2013","journal-title":"Cell Death Differ"},{"issue":"18","key":"2023071017373770400_bib17","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1182\/blood-2016-10-747436","article-title":"PUMILIO\/FOXP1 signaling drives expansion of hematopoietic stem\/progenitor and leukemia cells","volume":"129","author":"Naudin","year":"2017","journal-title":"Blood"},{"issue":"9","key":"2023071017373770400_bib18","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.freeradbiomed.2009.05.026","article-title":"The cell cycle is a redox cycle: linking phase-specific targets to cell fate","volume":"47","author":"Burhans","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"2023071017373770400_bib19","doi-asserted-by":"crossref","first-page":"108818","DOI":"10.1016\/j.cbi.2019.108818","article-title":"FOXP1 inhibits high glucose-induced ECM accumulation and oxidative stress in mesangial cells","volume":"313","author":"Xiang","year":"2019","journal-title":"Chem Biol Interact"},{"issue":"7","key":"2023071017373770400_bib20","doi-asserted-by":"crossref","first-page":"e0131674","DOI":"10.1371\/journal.pone.0131674","article-title":"Foxp1 regulates the proliferation of hair follicle stem cells in response to oxidative stress during hair cycling","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"key":"2023071017373770400_bib21","doi-asserted-by":"crossref","first-page":"106296","DOI":"10.1016\/j.leukres.2020.106296","article-title":"MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation","volume":"89","author":"Seipel","year":"2020","journal-title":"Leuk Res"},{"issue":"7","key":"2023071017373770400_bib22","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1158\/0008-5472.CAN-12-3955","article-title":"Differential contributions of STAT5A and STAT5B to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem\/progenitor cells","volume":"73","author":"Casetti","year":"2013","journal-title":"Cancer Res"},{"issue":"10","key":"2023071017373770400_bib23","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1182\/blood-2008-02-134411","article-title":"An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia","volume":"112","author":"Metzeler","year":"2008","journal-title":"Blood"},{"key":"2023071017373770400_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fonc.2017.00085","article-title":"The KEAP1-NRF2 system in cancer","volume":"7","author":"Taguchi","year":"2017","journal-title":"Front Oncol"},{"issue":"1","key":"2023071017373770400_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Quesada","year":"2011","journal-title":"Nat Genet"},{"issue":"5","key":"2023071017373770400_bib26","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1182\/blood-2007-09-115113","article-title":"Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL","volume":"111","author":"Brown","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2023071017373770400_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2007.02.001","article-title":"Foxo3a is essential for maintenance of the hematopoietic stem cell pool","volume":"1","author":"Miyamoto","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2023071017373770400_bib28","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1124\/mol.110.065714","article-title":"Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db\/db mice","volume":"78","author":"Nagashima","year":"2010","journal-title":"Mol Pharmacol"},{"issue":"5","key":"2023071017373770400_bib29","doi-asserted-by":"crossref","first-page":"e1007669","DOI":"10.1371\/journal.ppat.1007669","article-title":"FOXO1 transcription factor plays a key role in T cell-HIV-1 interaction","volume":"15","author":"Roux","year":"2019","journal-title":"PLoS Pathog"},{"issue":"5","key":"2023071017373770400_bib30","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41388-019-1044-7","article-title":"A\u00a0drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma","volume":"39","author":"Salcher","year":"2020","journal-title":"Oncogene"},{"issue":"2","key":"2023071017373770400_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrm3507","article-title":"FOXOs: signalling integrators for homeostasis maintenance","volume":"14","author":"Eijkelenboom","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2023071017373770400_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","article-title":"Mammalian sirtuins: biological insights and disease relevance","volume":"5","author":"Haigis","year":"2010","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"2023071017373770400_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrm3293","article-title":"Sirtuins as regulators of metabolism and healthspan","volume":"13","author":"Houtkooper","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"2023071017373770400_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2014.08.001","article-title":"SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells","volume":"15","author":"Li","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2023071017373770400_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood-2013-11-538819","article-title":"SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia","volume":"124","author":"Sasca","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2023071017373770400_bib36","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2010-03-273011","article-title":"SIRT1 deficiency compromises mouse embryonic stem cell hematopoietic differentiation, and embryonic and adult hematopoiesis in the mouse","volume":"117","author":"Ou","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2023071017373770400_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.stem.2008.01.002","article-title":"SIRT1 regulates apoptosis and nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization","volume":"2","author":"Han","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2023071017373770400_bib38","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.stemcr.2014.04.015","article-title":"Aging-like phenotype and defective lineage specification in SIRT1-deleted hematopoietic stem and progenitor cells","volume":"3","author":"Rimmel\u00e9","year":"2014","journal-title":"Stem Cell Rep"},{"issue":"5","key":"2023071017373770400_bib39","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1084\/jem.20121608","article-title":"Sirt1 ablation promotes stress-induced loss of epigenetic and genomic hematopoietic stem and progenitor cell maintenance","volume":"210","author":"Singh","year":"2013","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"2023071017373770400_bib40","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cmet.2017.10.013","article-title":"Resistance is futile: targeting mitochondrial energetics and metabolism to overcome drug resistance in cancer treatment","volume":"26","author":"Bosc","year":"2017","journal-title":"Cell Metab"},{"issue":"5","key":"2023071017373770400_bib41","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/10428194.2016.1228932","article-title":"The significance of FOXP1 in diffuse large B-cell lymphoma","volume":"58","author":"Gascoyne","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"2023071017373770400_bib42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12885-015-1282-1","article-title":"Tenovin-6-mediated inhibition of SIRT1\/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem\/progenitor cells","volume":"15","author":"Jin","year":"2015","journal-title":"BMC Cancer"},{"key":"2023071017373770400_bib43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/1471-2407-14-396","article-title":"FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities","volume":"14","author":"L\u2019Abbate","year":"2014","journal-title":"BMC Cancer"},{"issue":"2","key":"2023071017373770400_bib44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-8674(01)00524-4","article-title":"Negative control of p53 by Sir2alpha promotes cell survival under stress","volume":"107","author":"Luo","year":"2001","journal-title":"Cell"},{"issue":"2","key":"2023071017373770400_bib45","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","article-title":"Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib","volume":"21","author":"Li","year":"2012","journal-title":"Cancer Cell"},{"issue":"4","key":"2023071017373770400_bib46","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MOH.0000000000000152","article-title":"Role of SIRT1 in the growth and regulation of normal hematopoietic and leukemia stem cells","volume":"22","author":"Li","year":"2015","journal-title":"Curr Opin Hematol"},{"issue":"7","key":"2023071017373770400_bib47","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1172\/JCI127080","article-title":"SIRT1 regulates metabolism and leukemogenic potential in CML stem cells","volume":"129","author":"Abraham","year":"2019","journal-title":"J\u00a0Clin Invest"},{"issue":"11","key":"2023071017373770400_bib48","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1089\/scd.2012.0466","article-title":"Peroxisome proliferator-activated-\u03b3 coactivator-1\u03b1-mediated mitochondrial biogenesis is important for hematopoietic recovery in response to stress","volume":"22","author":"Basu","year":"2013","journal-title":"Stem Cells Dev"},{"issue":"24","key":"2023071017373770400_bib49","doi-asserted-by":"crossref","first-page":"12546","DOI":"10.18632\/aging.102587","article-title":"Sirt1-inducible deacetylation of p21 promotes cardiomyocyte proliferation","volume":"11","author":"Li","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"2023071017373770400_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejcb.2008.08.003","article-title":"Sirt1 increases skeletal muscle precursor cell proliferation","volume":"88","author":"Rathbone","year":"2009","journal-title":"Eur J Cell Biol"},{"issue":"12","key":"2023071017373770400_bib51","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2131\/jts.43.711","article-title":"SIRT1 knockdown up-regulates p53 and p21\/Cip1 expression in renal adenocarcinoma cells but not in normal renal-derived cells in a deacetylase-independent manner","volume":"43","author":"Fujino","year":"2018","journal-title":"J\u00a0Toxicol Sci"},{"issue":"1","key":"2023071017373770400_bib52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/1541-7786.MCR-14-0239","article-title":"SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27","volume":"13","author":"Zhu","year":"2015","journal-title":"Mol Cancer Res"},{"issue":"10","key":"2023071017373770400_bib53","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/s41556-020-00579-5","article-title":"SIRT1 is downregulated by autophagy in senescence and ageing","volume":"22","author":"Xu","year":"2020","journal-title":"Nat Cell Biol"},{"issue":"3","key":"2023071017373770400_bib54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tibs.2012.12.004","article-title":"The ways and means that fine tune Sirt1 activity","volume":"38","author":"Revollo","year":"2013","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"2023071017373770400_bib55","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.celrep.2014.05.016","article-title":"The ROS\/SUMO axis contributes to the response of acute myeloid leukemia cells to chemotherapeutic drugs","volume":"7","author":"Bossis","year":"2014","journal-title":"Cell Rep"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/13\/3265\/2062736\/blooda_adv-2022-008585-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/13\/3265\/2062736\/blooda_adv-2022-008585-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T17:39:03Z","timestamp":1689010743000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/13\/3265\/494958\/FOXP1-regulates-oxidative-stress-SIRT1-expression"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":55,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,7,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022008585","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]}}}